Raptor Pharmaceutica (RPTP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 08-2012 | |
| Sales | 94,240 | 69,497 | 16,872 | 0 | 0 |
| Cost of Goods | 12,621 | 9,416 | 1,653 | N/A | N/A |
| Gross Profit | 81,619 | 60,081 | 15,219 | N/A | N/A |
| Operating Expenses | 130,698 | 100,547 | 67,778 | 17,934 | 36,166 |
| Operating Income | -48,458 | -40,050 | -51,906 | -17,934 | -36,166 |
| Interest Expense | 15,793 | 13,971 | 6,832 | 83 | 3 |
| Other Income | -527 | 1,535 | -10,679 | -1,275 | -2,475 |
| Pre-tax Income | -64,778 | -52,486 | -69,417 | -19,292 | -38,644 |
| Income Tax | 444 | 54 | N/A | N/A | N/A |
| Net Income Continuous | -65,222 | -52,540 | -69,417 | -19,292 | -38,644 |
| Net Income | $-65,222 | $-52,540 | $-69,417 | $-19,292 | $-38,644 |
| EPS Basic Total Ops | -0.83 | -0.83 | -1.20 | -0.37 | -0.80 |
| EPS Basic Continuous Ops | -0.83 | -0.83 | -1.20 | -0.37 | -0.80 |
| EPS Diluted Total Ops | -0.83 | -0.83 | -1.20 | -0.37 | -0.80 |
| EPS Diluted Continuous Ops | -0.83 | -0.83 | -1.20 | -0.37 | -0.80 |
| EPS Diluted Before Non-Recurring Items | -0.83 | -0.83 | -1.01 | -0.76 | N/A |
| EBITDA(a) | $-45,622 | $-37,387 | $-51,036 | $-17,843 | $-35,955 |